USD 12.99
(0.62%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 231.7 Million CHF | -41.34% |
2022 | 394.98 Million CHF | -41.98% |
2021 | 680.72 Million CHF | -2.21% |
2020 | 696.11 Million CHF | 200.51% |
2019 | 231.64 Million CHF | 15.14% |
2018 | 201.19 Million CHF | 0.18% |
2017 | 200.82 Million CHF | 0.52% |
2016 | 199.78 Million CHF | 0.11% |
2015 | 199.57 Million CHF | 0.07% |
2014 | 199.44 Million CHF | 0.05% |
2013 | 199.34 Million CHF | 586202.94% |
2012 | 34 Thousand CHF | 0.0% |
2011 | - CHF | 0.0% |
2010 | - CHF | 0.0% |
2009 | - CHF | 0.0% |
2008 | - CHF | -100.0% |
2007 | 4.43 Million CHF | 0.0% |
2006 | - CHF | 0.0% |
2005 | - CHF | 0.0% |
2004 | - CHF | -100.0% |
2003 | 14.2 Million CHF | 0.0% |
2002 | 14.2 Million CHF | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 218.58 Million CHF | -5.66% |
2023 FY | 231.7 Million CHF | -41.34% |
2023 Q4 | 231.7 Million CHF | -42.05% |
2023 Q2 | 399.85 Million CHF | 1.23% |
2022 FY | 394.98 Million CHF | -41.98% |
2022 Q2 | 696.76 Million CHF | 2.36% |
2022 Q4 | 394.98 Million CHF | -43.31% |
2021 Q2 | 720.97 Million CHF | 3.57% |
2021 Q4 | 680.72 Million CHF | -5.58% |
2021 FY | 680.72 Million CHF | -2.21% |
2020 Q2 | 530.44 Million CHF | 129.0% |
2020 FY | 696.11 Million CHF | 200.51% |
2020 Q4 | 696.11 Million CHF | 31.23% |
2019 FY | 231.64 Million CHF | 15.14% |
2019 Q4 | 231.64 Million CHF | -13.37% |
2019 Q2 | 267.4 Million CHF | 32.91% |
2018 Q2 | 272.97 Million CHF | 35.93% |
2018 Q4 | 201.19 Million CHF | -26.3% |
2018 FY | 201.19 Million CHF | 0.18% |
2017 Q2 | 252.64 Million CHF | 26.46% |
2017 Q4 | 200.82 Million CHF | -20.51% |
2017 FY | 200.82 Million CHF | 0.52% |
2016 Q4 | 199.78 Million CHF | -0.18% |
2016 FY | 199.78 Million CHF | 0.11% |
2016 Q2 | 200.15 Million CHF | 0.29% |
2015 Q2 | 200.86 Million CHF | 0.72% |
2015 Q4 | 199.57 Million CHF | -0.65% |
2015 FY | 199.57 Million CHF | 0.07% |
2014 Q4 | 199.44 Million CHF | 0.04% |
2014 FY | 199.44 Million CHF | 0.05% |
2014 Q2 | 199.36 Million CHF | 0.01% |
2013 Q2 | 199.27 Million CHF | 586000.0% |
2013 FY | 199.34 Million CHF | 586202.94% |
2013 Q4 | 199.34 Million CHF | 0.03% |
2012 Q2 | - CHF | 0.0% |
2012 FY | 34 Thousand CHF | 0.0% |
2012 Q4 | 34 Thousand CHF | 0.0% |
2011 Q4 | - CHF | 0.0% |
2011 Q2 | - CHF | 0.0% |
2011 FY | - CHF | 0.0% |
2010 FY | - CHF | 0.0% |
2010 Q4 | - CHF | 0.0% |
2010 Q2 | - CHF | 0.0% |
2009 Q4 | - CHF | 0.0% |
2009 FY | - CHF | 0.0% |
2008 FY | - CHF | -100.0% |
2007 FY | 4.43 Million CHF | 0.0% |
2006 FY | - CHF | 0.0% |
2005 FY | - CHF | 0.0% |
2004 FY | - CHF | -100.0% |
2003 FY | 14.2 Million CHF | 0.0% |
2002 FY | 14.2 Million CHF | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
American Medical Technologies Inc. | - USD | -Infinity% |
Ansell Limited | 705.27 Million USD | 67.147% |
Ansell Limited | 706.6 Million USD | 67.208% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 22.41 Million USD | -933.877% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | - USD | -Infinity% |
Psykey, Inc. | 625 Thousand USD | -36973.28% |
ConvaTec Group Plc | 1.22 Billion USD | 81.088% |
ConvaTec Group Plc | 1.22 Billion USD | 81.114% |
Encision Inc. | 67.33 Thousand USD | -344007.164% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | - USD | -Infinity% |
Innovative MedTech Inc. | 382.83 Thousand USD | -60423.931% |
LifePoint, Inc. | 151.73 Thousand USD | -152606.71% |
Medite Cancer Diagnostics, Inc. | 4.91 Million USD | -4615.263% |
Paradigm Medical Industries, Inc. | 615 Thousand USD | -37576.098% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | - USD | -Infinity% |
Reflect Scientific, Inc. | 179.96 Thousand USD | -128653.133% |
SmileDirectClub, Inc. | 849.37 Million USD | 72.72% |
Sector 10, Inc. | - USD | -Infinity% |
Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | -9.929% |
SheerVision, Inc. | - USD | -Infinity% |
United Health Products, Inc. | 48.48 Thousand USD | -477756.834% |
Vasamed, Inc. | 18.95 Thousand USD | -1222633.509% |
Wearable Health Solutions, Inc. | 18.46 Thousand USD | -1254545.874% |
Yubo International Biotech Limited | 390.44 Thousand USD | -59244.594% |